

Ginkgo Bioworks offers remote autonomous lab access to NSF X-Labs and integrates Araceli imaging into its Boston platform.
You can purchase shares of Ginkgo Bioworks Holdings (NYSE:DNA) through any online brokerage.
Other companies in Ginkgo Bioworks Holdings’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Ginkgo Bioworks Holdings has a consensus price target of $48.00.
The stock price for Ginkgo Bioworks Holdings (NYSE: DNA) is $11.3925 last updated November 6, 2026 at 7:27 PM EST.
There are no upcoming dividends for Ginkgo Bioworks Holdings.
Ginkgo Bioworks Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Ginkgo Bioworks Holdings.
Ginkgo Bioworks Holdings is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty...